Fábio Vidal and colleagues [27] found that periodontitis therapy reduces plasma levels of Interleukin-6, C-Reactive Protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. This evidence concerns the gene IL6 and periodontitis.